The Carmel Medical Center's Innovation Center, in collaboration with Clalit, Mon4t, and the Ophthalmology Department, is leading a fundamental change in the treatment of multiple sclerosis patients with the development of an innovative digital test for visual acuity.
The new development will enable continuous and advanced monitoring of patients' neurological condition and provide doctors with precise tools to tailor personalized treatment and identify worsening of their disease at an early stage.
The innovative test will be performed using a dedicated application, which allows for convenient testing from home and the transmission of data directly to medical teams in Carmel.
Personalized medicine using advanced technology
Dr. Daniel Golan, Director of the Multiple Sclerosis and Neuroimmunology Clinic in Carmel:
"The implementation of Mon4t's digital tools allows us to obtain a more continuous and accurate clinical picture. Adding visual acuity testing as part of our testing suite will help improve the medical decision-making process and tailor optimal treatment to each patient."
Dr. Alawit Wolf, Director of the Pediatric Ophthalmology Unit and Medical Director at the Carmel Innovation Center, adds: "This is a breakthrough that will change the way multiple sclerosis patients are monitored. The test will make diagnosis accessible, enable early identification of changes, and provide an innovative and personalized medical approach."
The new technology is expected to be integrated into Clalit's healthcare system and be accessible to patients across the country.
The digital health revolution – in Carmel and in general:
Prof. Ran Blitzer, Head of Innovation at Clalit, and Dr. Sharon Kama, Deputy Director of Carmel and Director of the hospital's Innovation Center, emphasize: "We are proud to lead innovative technological projects as part of our vision to promote digital health in Israel. The new development will allow us to provide advanced, continuous, and more accessible care to all patients."
In addition, the test is expected to be integrated into additional Clalit projects in the field of remote medicine, along with the use of artificial intelligence to identify unusual patterns and provide alerts to medical teams in the event of a worsening of the patient's condition.
Making treatment accessible and improving patients' quality of life
Dr. Ziv Yekutieli, CEO of Mon4t, concludes and says: "The collaboration with Carmel and Klelit places us at the forefront of medical innovation. The new test will enable self-monitoring from home, reduce the need for clinic visits and significantly improve the quality of life of multiple sclerosis patients."
Patients will be able to test their visual acuity in real time, receive immediate results, and consult with their doctors without having to physically visit a clinic. The development is expected to save time, reduce burdens on the healthcare system, and improve the ability to monitor complex medical conditions.
The innovative test will be developed in close collaboration between medical teams, researchers, and development personnel, and will make digital medicine a central tool in neurological treatment, with the aim of expanding its use to additional diseases that require constant medical monitoring.
How can I make an appointment?